Injection of isolated mitochondria during early reperfusion for cardioprotection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 1, 2009, Pages

  McCully, James D ^a   Cowan, Douglas B ^b   Pacak, Christina A ^b   Toumpoulis, Ioannis K ^a   Dayalan, Haripriya ^a   Levitsky, Sidney ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Apoptosis; Infarct; Ischemia

Indexed keywords

CREATINE KINASE; CREATININE KINASE MB; TROPONIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREATHING; CELL VIABILITY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; FEMALE; FUNCTIONAL STATUS; HEART; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INJECTION; ISOLATED HEART; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; RABBIT; RISK FACTOR; SHAM PROCEDURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CASPASES; CREATINE KINASE; FEMALE; HEART RATE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, CONFOCAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION; RABBITS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TROPONIN C; VENTRICULAR FUNCTION, LEFT;

EID: 58149512743     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00567.2008     Document Type: Article

References (42)

1. Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complex I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metab Biol 51: 35-42, 1994.
2. Bolling SF, Bies LE, Bove EL. Effect of ATP synthesis promoters on postischemic myocardial recovery. J Surg Res 49: 205-211, 1990.
3. Dai W, Field LJ, Rubart M, Reuter S, Hale SL, Zweigerdt R, Graichen RE, Kay GL, Jyrala AJ, Colman A, Davidson BP, Pera M, Kloner RA. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 43: 504-516, 2007.
4. Dost T, Cohen MV, Downey JM. Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning. Basic Res Cardiol 103: 378-384, 2008.
5. Feinberg H, Levitsky S, Lee SL. The quiescent heart: excitability, compliance, and vascular resistance. Am J Physiol Heart Circ Physiol 251: H1085-H1089, 1986.
6. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann S, Ulmann C, Lorenz-Meyer S, Schaper U. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32: 197-208, 2000.
7. Hagège AA, Carrion C, Menasché P, Vilquin JT, Duboc D, Marolleau JP, Desnos M, Bruneval P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361: 491-492, 2003.
8. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
9. 1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent. Am J Physiol Heart Circ Physiol 289: H785-H791, 2005.
10. Lebuffe G, Schumacker PT, Shao ZH, Anderson T, Iwase H, Vanden Hoek TL. ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 284: H299-H308, 2003.
11. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tander B, Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258-H267, 2004.
12. Levitsky S, Laurikka J, Stewart RD, Campos CT, Lahey SJ, McCully JD. Mitochondrial DNA deletions in coronary artery bypass grafting patients. Eur J Cardiothorac Surg 24: 777-784, 2003.
13. Levy RJ, Deutschman CS. Cytochrome c oxidase dysfunction in sepsis. Crit Care Med 35: S468-S475, 2007.
14. Liu Y, Yang XM, Iliodromitis EK, Kremastinos DT, Dost T, Cohen MV, Downey JM. Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator. Basic Res Cardiol 103: 54-59, 2008.
15. McCully JD, Rousou AJ, Parker RA, Levitsky S. Age and gender differences in mitochondrial oxygen consumption and free matrix calcium during ischemia/reperfusion and with cardioplegia and diazoxide. Ann Thorac Surg 83: 1102-1109, 2007.
16. McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S. Age and gender related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide. Ann Thorac Surg 82: 117-123, 2006.
17. McCully JD, Wakiyama H, Cowan DB, Federman M, Levitsky S. Diazoxide amelioration of myocardial injury and mitochondrial damage during cardiac surgery. Ann Thorac Surg 74: 2138-2146, 2002.
18. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S. Differential contribution of necrosis and apoptosis in myocardial ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol 286: H1923-H1935, 2004.
19. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294, 2006.
20. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112: 3174-3183, 2005.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animals tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
22. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York: Academic, 1972, p. 151-156.
23. Olson MS, Von Korff RW. Changes in endogenous substrates of isolated rabbit heart mitochondria during storage. J Biol Chem 242: 325-332, 1967.
24. O'Rourke B. Mitochondrial ion channels. Annu Rev Physiol 69: 19-49, 2007.
25. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41: 879-888, 2003.
26. 10 in cardiovascular disease. Mitochondrion 7: Suppl S154-S167, 2007.
27. Piel DA, Gruber PJ, Weinheimer CJ, Courtois MR, Robertson CM, Coopersmith CM, Deutschman CS, Levy RJ. Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med 35: 2120-2127, 2007.
28. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res 61: 365-371, 2004.
29. 10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 21: 297-306, 2007.
30. Rousou AJ, Ericsson M, Federman M, Levitsky S, McCully JD. Diazoxide and cardioplegia ameliorate ischemia/reperfusion cell death through the modulation of mitochondrial volume and calcium accumulation and mitochondrial respiratory control index. Am J Physiol Heart Circ Physiol 287: H1967-H1976, 2004.
31. Soncul H, Ersoz A, Gokgoz L, Karasu C, Ayrancioglu K, Sinci V, Altan M. Cardioplegia with adenosine and adenosine triphosphate in the isolated guinea pig heart. Jpn Heart J 33: 843-850, 1992.
32. Stark G, Domanowits H, Sterz F, Stark U, Bachernegg M, Kickenweiz E, Decrinis M, Laggner AN, Tritthart HA. Action of ATP on ventricular automaticity. J Cardiovasc Pharmacol 24: 740-744, 1994.
33. Tansey EE, Kwaku Hammer PE KF, Cowan DB, Federman M, Levitsky S, McCully JD. Reduction and redistribution of gap and adherens junction proteins following ischemia/reperfusion. Ann Thorac Surg 82: 1472-1479, 2006.
34. 10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28: 2249-2255, 2007.
35. Toyoda Y, Di Gregorio V, Parker RA, Levitsky S, McCully JD. Anti-stunning and anti-infarct effects of adenosine enhanced ischemic preconditioning. Circulation 102: 326-331, 2000.
36. Toyoda Y, Levitsky S, McCully JD. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection. Ann Thorac Surg 71: 1281-1289, 2001.
37. Vinten-Johansen J. Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 12: 235-244, 2007.
38. Wakiyama H, Cowan DB, Toyoda Y, Federman M, Levitsky S, McCully JD. Selective opening of mitochondrial ATP-sensitive potassium channels during cardiopulmonary bypass decreases apoptosis and necrosis in a model of acute myocardial infarction. Eur J Cardiothorac Surg 21: 424-433, 2002.
39. Wechsler MB. Studies on oxidative phosphorylation and ATPase activity of fresh and frozen brain mitochondria. Arch Biochem Biophys 95: 494-498, 1961.
40. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Caffrey JL, Vinten-Johansen J. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294: H1444-H1451, 2008.
41. Zhang D, Lu C, Whiteman M, Chance B, Armstrong JS. The mitochondrial permeability transition regulates cytochrome c release for apoptosis during endoplasmic reticulum stress by remodeling the cristae junction. J Biol Chem 283: 3476-3486, 2008.
42. 1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol 130: 1115-1123, 2000.